¼¼°èÀÇ ÀÇ·á±â±â ¼­µåÆÄƼ ±³Á¤ ¼­ºñ½º ½ÃÀå
Medical Equipment Third Party Calibration Services
»óǰÄÚµå : 1787125
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 260 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,274,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,824,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ÀÇ·á±â±â ¼­µåÆÄƼ ±³Á¤ ¼­ºñ½º ½ÃÀåÀº 2030³â±îÁö 9¾ï 7,330¸¸ ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 6¾ï 2,450¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ÀÇ·á±â±â ¼­µåÆÄƼ ±³Á¤ ¼­ºñ½º ¼¼°è ½ÃÀåÀº 2024-2030³âÀÇ ºÐ¼® ±â°£¿¡ CAGR 7.7%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 9¾ï 7,330¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ º´¿øÀº CAGR 9.0%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 6¾ï 3,050¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÓ»ó °Ë»ç ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 5.2%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 1¾ï 7,010¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR12.2%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÀÇ·á±â±â ¼­µåÆÄƼ ±³Á¤ ¼­ºñ½º ½ÃÀåÀº 2024³â¿¡ 1¾ï 7,010¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â°£ CAGR 12.2%·Î 2030³â±îÁö ¿¹Ãø ½ÃÀå ±Ô¸ð 2¾ï 950¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 3.8%¿Í 7.5%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 5.1%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ÀÇ·á±â±â ¼­µåÆÄƼ ±³Á¤ ¼­ºñ½º ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

͏®ºê·¹ÀÌ¼Ç ¾Æ¿ô¼Ò½ÌÀº ÀÇ·á±â±âÀÇ ½Å·Ú¼ºÀ» µÞ¹ÞħÇÏ´Â ¼ûÀº ÁßÃßÀΰ¡?

ÀÇ·á±â±â ±³Á¤Àº Çö´ë ÀÇ·á ¼­ºñ½º¿¡¼­ ¹Ì¼Ç Å©¸®Æ¼ÄÃÇÑ ¿ä¼Ò·Î ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ º´¿ø°ú Áø´Ü¼¾ÅͰ¡ ÃÖÀûÀÇ È¯ÀÚ Ä¡·á¸¦ º¸ÀåÇϱâ À§ÇØ °íÁ¤¹Ð ±â¼ú¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³ôÀ̰í Àֱ⠶§¹®ÀÔ´Ï´Ù. Á¦3ÀÚ ±³Á¤ ¼­ºñ½º´Â ´Ù¾çÇÑ ÀÇ·á±â±â ±ÔÁ¦, ¿î¿µ ¹× ÀÓ»ó ¿ä°ÇÀ» Áö¿øÇÏ´Â Àü¹®ÀûÀÌ°í °øÀÎµÈ Àü¹® Áö½ÄÀ» Á¦°øÇÏ´Â Àü·«Àû Áö¿øÀÚ·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. »ç³» À¯Áöº¸¼ö ¸ðµ¨¿¡¼­ ±³Á¤ ¾Æ¿ô¼Ò½Ì ¸ðµ¨·ÎÀÇ ÀüȯÀº ºü¸¥ ó¸® ½Ã°£, Á¤È®µµ Çâ»ó, ISO/IEC 17025¿Í °°Àº ±¹Á¦ Ç¥ÁØ Áؼö¿¡ ´ëÇÑ ¿ä±¸·Î ÀÎÇØ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ç¥ÁØÀº ±³Á¤ °á°úÀÇ ½Å·Ú¼ºÀ» º¸ÀåÇÒ »Ó¸¸ ¾Æ´Ï¶ó ÀÇ·á±â°üÀÇ ÃßÀû¼º ¹× °¨»ç ´ëÀÀ·ÂÀ» °­È­ÇÕ´Ï´Ù. »ç³» ¹ÙÀÌ¿À¸ÞµðÄà ¿£Áö´Ï¾î¸µ ºÎ¼­´Â ÇöÀçµµ Á¤±âÀûÀÎ ¼­ºñ½º¸¦ Á¦°øÇϰí ÀÖÁö¸¸, ƯÈ÷ °í±Þ ¿µ»óó¸®, ¼ö¾×, Áø´Ü ½Ã½ºÅÛ µî °íÁ¤¹Ð ±³Á¤¿¡ ÇÊ¿äÇÑ ÀÎÁõ ¹× ȯ°æ°ü¸®°¡ ºÎÁ·ÇÑ °æ¿ì°¡ ¸¹½À´Ï´Ù. µû¶ó¼­ ȯ°æÀûÀ¸·Î °ü¸®µÇ´Â ½ÇÇè½Ç, ÀÚµ¿È­µÈ ±³Á¤ Àåºñ ¹× Å©·Î½º Ç÷§Æû ±â±â Å×½ºÆ® ±â´ÉÀ» °®Ãá µ¶¸³ÀûÀÎ ±³Á¤ ȸ»ç¿¡ ±æÀ» ¿­¾îÁÖ°í ÀÖ½À´Ï´Ù. Àü ¼¼°è ÇコÄɾ ¿¹¹æÀû À¯Áöº¸¼ö ¸ðµ¨·Î ÀüȯÇÏ´Â °¡¿îµ¥, Á¦3ÀÚ ±³Á¤Àº ÀåºñÀÇ ´Ù¿îŸÀÓÀ» ÁÙÀ̰í ÀåºñÀÇ ¼ö¸íÁֱ⸦ ¿¬ÀåÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, MRI ½ºÄ³³Ê, ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ, ÁÖÀÔ ÆßÇÁ µî ÀÇ·á±â¼úÀÌ º¹ÀâÇØÁü¿¡ µû¶ó ³»ºÎ¿¡¼­ È¿À²ÀûÀ¸·Î °ü¸®ÇÒ ¼ö ¾ø´Â Àü¹®°¡ÀÇ ±³Á¤ °³ÀÔÀÌ ÇÊ¿äÇÏ°Ô µÇ¾ú½À´Ï´Ù. Ÿ»ç ±³Á¤ »ê¾÷Àº ´Ü¼øÈ÷ °ÝÂ÷¸¦ ÇØ¼ÒÇÏ´Â °Í»Ó¸¸ ¾Æ´Ï¶ó °ø°ø ¹× ¹Î°£ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üÀÇ ¹ë·ùüÀÎÀ» ÃÖÀûÈ­Çϰí ÀÖ½À´Ï´Ù.

±ÔÁ¦ ¹× ±ÔÁ¤ Áؼö¿¡ ´ëÇÑ ¾Ð·ÂÀº ±³Á¤ Àü¹®°¡¿¡ ´ëÇÑ ¼ö¿ä¸¦ ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?

¼¼°èÀûÀ¸·Î ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿¡ ´ëÇÑ ±ÔÁ¦ ºÎ´ãÀÌ Áõ°¡ÇÔ¿¡ µû¶ó, ÃßÀû °¡´ÉÇÏ°í ¹®¼­È­µÇ¾î ÀÖÀ¸¸ç Ç¥ÁØÀ» ÁؼöÇÏ´Â ±³Á¤ ¼­ºñ½ºÀÇ Á߿伺ÀÌ ±Þ°ÝÈ÷ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ FDA, À¯·´ÀǾàǰû, °¢±¹ º¸°ÇÀÇ·áÀ§¿øÈ¸ µî ´Ù¾çÇÑ Áö¿ª ±ÔÁ¦±â°üÀº ǰÁú°ü¸®ÀÇ ÀÏȯÀ¸·Î ÀÇ·á±â±âÀÇ Á¤±âÀûÀÎ ±³Á¤À» Àǹ«È­Çϰí ÀÖ½À´Ï´Ù. À̸¦ ÁöŰÁö ¾ÊÀ» °æ¿ì, ó¹úÀ̳ª ¼­ºñ½º Áß´Ü, ȤÀº ÀåºñÀÇ ºÎÁ¤È®¼ºÀ¸·Î ÀÎÇÑ Áø´Ü ¿À·ù³ª Ä¡·á ½ÇÆÐÀÇ °æ¿ì ȯÀÚ ¼Ò¼ÛÀ¸·Î±îÁö ¹ßÀüÇÒ ¼ö ÀÖ½À´Ï´Ù. Á¦3ÀÚ ±³Á¤ ¾÷ü´Â º¥´õ°¡ ¾Æ´Ñ ÄÄÇöóÀ̾𽺠ÆÄÆ®³Ê·Î °£Áֵǰí ÀÖÀ¸¸ç, ¿£µå Åõ ¿£µå ¹®¼­È­, °¨»ç Áö¿ø, ÁøÈ­Çϴ ǥÁØ ¹× °Ë»ç ¿ä±¸ »çÇ׿¡ µû¸¥ ±³Á¤ ÀÎÁõ¼­¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ȯÀÚ ¾ÈÀü¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ƯÈ÷ ¹æ»ç¼±°ú, ¿Ü°ú, ¼øÈ¯±â³»°ú, ÁßȯÀڽǰú °°Àº °íÀ§Çè Áø·á°ú¿¡¼­ ÀåºñÀÇ ½Å·Ú¼º¿¡ ´ëÇÑ ¾ö°ÝÇÑ ÇÁ·ÎÅäÄÝÀÌ °­È­µÇ°í ÀÖ½À´Ï´Ù. ¼ö¾×·®, ECG ½ÅÈ£, ÀΰøÈ£Èí±â ¾Ð·Â µî ±â±âÀÇ ÃøÁ¤°ª¿¡ ¾à°£ÀÇ ¿ÀÂ÷°¡ À־ ½É°¢ÇÑ ÀÓ»ó °á°ú·Î À̾îÁú ¼ö Àֱ⠶§¹®¿¡ Àü¹®°¡ ÁÖµµÀÇ Ä¶¸®ºê·¹À̼ÇÀÇ Çʿ伺ÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù. ͏®ºê·¹À̼ÇÀº ÀÓ»óÀû ¿¬°ü¼º»Ó¸¸ ¾Æ´Ï¶ó ½Ä½º ½Ã±×¸¶(Six Sigma), °øµ¿À§¿øÈ¸ ÀÎÁõ µî º´¿ø ÀüüÀÇ Ç°Áú º¸Áõ ¸ñÇ¥µµ Áö¿øÇÕ´Ï´Ù. ¹«¼± ¼ö¾× ÁÖÀÔ ½Ã½ºÅÛ, ÈÞ´ë¿ë Áø´Ü ÀåÄ¡, ·Îº¿ º¸Á¶ ¼ö¼ú ÀåÄ¡¿Í °°Àº »õ·Î¿î ±â¼úÀÌ º¸±ÞµÊ¿¡ µû¶ó ±ÔÁ¦ ´ç±¹µµ ÀÌ¿¡ ´ëÀÀÇϱâ À§ÇØ ±³Á¤ ÇÁ·ÎÅäÄÝÀ» ¾÷µ¥ÀÌÆ®Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ÀÇ·á ±â°üµéÀº ÃßÀû¼º, µ¥ÀÌÅÍ ·Î±ë, ¼º´É ºÐ¼®, ¿ø°Ý Áø´ÜÀ» ÅëÇØ °íÀåÀ» »çÀü¿¡ °¨ÁöÇÒ ¼ö ÀÖ´Â ±³Á¤ Àü¹®°¡¿¡°Ô ÁÖ¸ñÇϰí ÀÖ½À´Ï´Ù. °ú°Å¿¡´Â üũ¹Ú½º·Î ¿©°ÜÁ³´ø ÄÄÇöóÀ̾𽺴 ÀÌÁ¦ ½áµåÆÄƼ ±³Á¤ »ýŰèÀÇ È®ÀåÀ» ÃËÁøÇÏ´Â ÇÙ½ÉÀûÀÎ ¾÷¹«Àû Çʼö ¿ä¼Ò·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù.

¼­ºñ½º »ê¾÷ »óȲÀ» ÃËÁøÇÏ´Â µ¥ ÀÖ¾î ÃÖÁ¾ »ç¿ë »ê¾÷°ú ÀåºñÀÇ º¹À⼺ÀÌ ¾î¶² ¿ªÇÒÀ» Çϴ°¡?

Ÿ»ç ±³Á¤ ¼­ºñ½ºÀÇ ¹üÀ§´Â º´¿ø, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), º´¸® °Ë»ç½Ç, ÀçÅÃÄ¡·á Á¦°ø¾÷ü, ¿µ»ó Áø´Ü Ŭ¸®´Ð µî ´Ù¾çÇÑ ÃÖÁ¾ »ç¿ë ¼öÁ÷ ºÐ¾ß¿¡¼­ ºü¸£°Ô È®ÀåµÇ°í ÀÖ½À´Ï´Ù. °¢ ºÎ¹®Àº Àåºñ »ç¿ë ÆÐÅÏ, À§Çè ÇÁ·ÎÆÄÀÏ, ¼­ºñ½º ºóµµ ¿ä±¸»çÇ׿¡ µû¶ó °³º°ÀûÀÎ ±³Á¤ ¿ä±¸»çÇ×ÀÌ ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ÀÀ±Þ½ÇÀ̳ª ÁßȯÀڽǰú °°ÀÌ »ç¿ë ºóµµ°¡ ³ôÀº ȯ°æ¿¡¼­´Â ȯÀÚ ¸ð´ÏÅÍ, Á¦¼¼µ¿±â, ¸¶Ãë °ø±Þ ½Ã½ºÅÛÀ» ´õ ÀÚÁÖ ±³Á¤ÇÏ¿© ¼¾¼­ µå¸®ÇÁÆ® ¹× ¸Å°³º¯¼ö ÆíÂ÷ÀÇ À§ÇèÀ» ÁÙ¿©¾ß ÇÕ´Ï´Ù. ÇÑÆí, ¿Ü·¡ Áø·á½Ç¿¡¼­´Â ECG ÀåÄ¡, ½ºÇǷιÌÅÍ, µðÁöÅÐ ¿Âµµ°è µî °£ÇæÀûÀ¸·Î »ç¿ëµÇ´Â Á¤¹Ðµµ°¡ ¿ä±¸µÇ´Â µµ±¸ÀÇ ±³Á¤¿¡ ÀÇÁ¸ÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ¶ÇÇÑ, ¸ð¹ÙÀÏ ÇコÄɾî¿Í ¿ø°ÝÀÇ·áÀÇ È®»ê¿¡ µû¶ó ÈÞ´ë¿ë ÃÊÀ½ÆÄ ÇÁ·Îºê, ÇöÀåÁø´Ü±â±â µî ÈÞ´ë¿ë ÀÇ·á±â±âµµ ±³Á¤ ´ë»ó¿¡ Æ÷ÇԵǰí ÀÖ½À´Ï´Ù. ÀÇ·á±â±âÀÇ ¼ÒÇüÈ­ ¹× µðÁöÅÐÈ­¿¡ µû¶ó ¿©·¯ ¼¾¼­¿Í ¸ðµâ¿¡ °ÉÄ£ ÃÊÁ¤¹Ð Á¤·Ä, ¼ÒÇÁÆ®¿þ¾î µ¿±âÈ­, °ËÁõÀÌ ¿ä±¸µÇ´Â °ÍÀÌ °úÁ¦ÀÔ´Ï´Ù. ÇöÀç Ÿ»ç Á¦°ø¾÷üµéÀº Ŭ¶ó¿ìµå ±â¹Ý ±³Á¤ °ü¸® ¼ÒÇÁÆ®¿þ¾î¿¡ ÅõÀÚÇÏ¿© Àç°í ÃßÀû, ±³Á¤ ½ºÄÉÁÙ¸µ, ÀÌ·Â ºÐ¼®À» ÀÚµ¿È­ÇÏ¿© ¹æ´ëÇÑ ÇコÄÉ¾î ³×Æ®¿öÅ©ÀÇ ¿ä±¸¸¦ ÃæÁ·½Ã۰í ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ¿©·¯ ÁöÁ¡À» º¸À¯ÇÑ ÇコÄɾî üÀÎÀº Áß¾Ó ¸ð´ÏÅ͸µÀ» À¯ÁöÇϸ鼭 Àüü ±³Á¤ ¿öÅ©Ç÷ο츦 ¾Æ¿ô¼Ò½ÌÇÒ ¼ö ÀÖ¾î ¾÷¹« È¿À²¼ºÀ» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á±â±â OEMÀº µ¶¸³ÀûÀÎ ±³Á¤¾÷ü¿Í Àü·«Àû Á¦ÈÞ¸¦ ¸Î°í ÆÇ¸Å ÈÄ À¯Áöº¸¼ö ¹× ÄÄÇöóÀ̾𽺠¼­ºñ½º¸¦ ¼­ºñ½º ¼öÁØ °è¾à(SLA)ÀÇ ÀϺηΠ¹øµé¸µÇÏ¿© ÃÖÁ¾ »ç¿ëÀÚÀÇ ºÎ´ãÀ» ´ú¾îÁÖ°í ÀÖ½À´Ï´Ù. ½ÅÈï ½ÃÀå Àü¹Ý¿¡¼­ ¹Î°ü ÆÄÆ®³Ê½ÊÀÌ Áõ°¡ÇÔ¿¡ µû¶ó, ƯÈ÷ Á¤ºÎ ÅõÀÚ ½Ã¼³ÀÇ °æ¿ì, Áö¿ª ÀÎÁõÀ» ¹ÞÀº Á¦3ÀÚ ±³Á¤ ¼¾ÅÍ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÀÇ·á±â±â Á¦3ÀÚ ±³Á¤ ¼­ºñ½º ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÃÊ·¡µË´Ï´Ù.

ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå µ¿·ÂÀº ÇコÄɾîÀÇ µðÁöÅÐÈ­, ÀåºñÀÇ °íµµÈ­, ±ÔÁ¦ Åõ¸í¼º¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ±â¼ú Ãø¸é¿¡¼­´Â µðÁöÅÐ ¿¢½º·¹ÀÌ ÃÔ¿µ±â, Ç÷¾× Åõ¼®±â, ·Îº¿ ¼ö¼ú Ç÷§Æû¿¡ À̸£±â±îÁö ÷´Ü Áø´Ü ¹× Ä¡·á ½Ã½ºÅÛÀÇ ±ÞÁõÀ¸·Î ÀÎÇØ Á¤È®ÇÏ°í ºó¹øÇÑ ÀÎÁõ ±³Á¤ ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ¼ÒÇÁÆ®¿þ¾î¿¡ ÅëÇÕµÈ Çϵå¿þ¾î ºÎǰ¿¡ Å©°Ô ÀÇÁ¸Çϱ⠶§¹®¿¡ ¼¾¼­ Á¤·Ä, Ãâ·Â º¸Á¤, Àü·Â ÃøÁ¤ ±âÁØ µîÀÇ ¹Ì¼¼ÇÑ º¯µ¿¿¡ ¸Å¿ì ¹Î°¨ÇÕ´Ï´Ù. ±× °á°ú, °Å·¡Ã³ »óÇ¥ Á¦Ç° Á¦Á¶¾÷ü´Â ÀåºñÀÇ ¹«°á¼ºÀ» À¯ÁöÇÏ°í º¸ÁõÀÇ À¯È¿¼ºÀ» À¯ÁöÇϱâ À§ÇØ Á¦3ÀÚ ±â°ü¿¡ ÀÇÇÑ ±³Á¤À» Á¡Á¡ ´õ ¸¹ÀÌ ±ÇÀåÇϰí ÀÖ½À´Ï´Ù. ÃÖÁ¾ »ç¿ëÀÚ Ãø¸é¿¡¼­´Â ºñ¿ë Àý°¨°ú ¾÷¹« ¾Æ¿ô¼Ò½ÌÀÇ Ãß¼¼¿¡ µû¶ó º´¿ø°ú ¿¬±¸¼Ò´Â ±³Á¤ ¾÷¹«¸¦ Àü¹® ¾÷ü¿¡ À§Å¹ÇÏ¿© »ç³» ¾÷¹« ºÎ´ãÀ» ÁÙÀ̸鼭 ¼­ºñ½º ǰÁúÀ» Çâ»ó½ÃŰ·Á Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ´ëÇü º´¿ø¿¡¼­´Â ¿©·¯ º¥´õÀÇ Àåºñ Æ÷Æ®Æú¸®¿À°¡ ÁÖ·ù¸¦ ÀÌ·ç°í Àֱ⠶§¹®¿¡ Ÿ»ç Á¦°ø¾÷ü´Â OEMÀÇ Á¦¾à¿¡ ±¸¾Ö¹ÞÁö ¾Ê´Â Å©·Î½º Ç÷§Æû ±³Á¤À̶ó´Â °íÀ¯ÇÑ ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. ¼ÒºñÀÚ Çൿµµ ÁøÈ­Çϰí ÀÖÀ¸¸ç, ÀÇ·á ±â°üÀº ÇöÀç ±³Á¤ ÀÌ·ÂÀÇ ½Ç½Ã°£ ÃßÀû, ¿¹Ãø À¯Áö º¸¼ö ºÐ¼®, Áß¾Ó ÁýÁᫎ º´¿ø ÀÚ»ê °ü¸® ½Ã½ºÅÛ¿¡ ±³Á¤ µ¥ÀÌÅÍ ÅëÇÕÀ» ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±ÔÁ¦ ȯ°æÀÌ Á¡Á¡ ´õ ÁÁ¾ÆÁö°í ÀÖÀ¸¸ç, ¹Î°£ ºÎ¹®°ú °ø°ø ºÎ¹® ¸ðµÎ¿¡¼­ ±ÔÁ¤ Áؼö¿Í ǰÁúÀ» º¸ÀåÇϱâ À§ÇØ ±¹°¡ ÀÇ·á ±â°üÀÌ Å¸»ç ±³Á¤À» ½ÂÀÎÇϰí ÀÖ½À´Ï´Ù. À¯·´°ú ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­´Â µðÁöÅÐ ÀÇ·á ÇÁ·Î±×·¥ ¹× ½º¸¶Æ® º´¿øÀÇ È®´ë·Î ÀÎÇØ Á¤¹ÐÀÇ·á±â±â ¼³Ä¡°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ¿¡ µû¶ó ÀÎÁõ ±³Á¤¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±â¼úÀÚ°¡ ÀÇ·á½Ã¼³À» ¹æ¹®ÇÏ¿© ÀÏ»ó ¾÷¹«¿¡ ÁöÀåÀ» ÁÖÁö ¾Ê°í ÇöÀå ±³Á¤À» ¼öÇàÇÏ´Â ¸ð¹ÙÀÏ ±³Á¤ ¼­ºñ½ºÀÇ µîÀåÀº ¼­ºñ½º ÀÌ¿ëÀÇ ÆíÀǼº°ú º¸±Þ¿¡ ´õ¿í ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¿ä¾àÇϸé, ÀÌ ½ÃÀåÀº ±â¼ú Çõ½Å, ÀåºñÀÇ »óÈ£ ÀÇÁ¸¼º Áõ°¡, ÃÖÁ¾ »ç¿ëÀÚ ¼ö¿äÀÇ ´Ù¾çÈ­, ÄÄÇöóÀ̾𽺠Àǹ« °­È­ µîÀÌ °áÇյǾî Çü¼ºµÇ°í ÀÖÀ¸¸ç, ÀÌ ¸ðµç °ÍÀÌ ¼¼°è ÇコÄÉ¾î ºÐ¾ß¿¡¼­ Á¦3ÀÚ ±³Á¤ ¼­ºñ½ºÀÇ °¡Ä¡ Á¦¾ÈÀ» °­È­Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

¿ëµµ(º´¿ø, ÀÓ»ó½ÇÇè½Ç, ±âŸ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

´ç»ç´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Äõ¸® ÇÏ´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Medical Equipment Third Party Calibration Services Market to Reach US$973.3 Million by 2030

The global market for Medical Equipment Third Party Calibration Services estimated at US$624.5 Million in the year 2024, is expected to reach US$973.3 Million by 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$630.5 Million by the end of the analysis period. Growth in the Clinical Laboratories segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$170.1 Million While China is Forecast to Grow at 12.2% CAGR

The Medical Equipment Third Party Calibration Services market in the U.S. is estimated at US$170.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$209.5 Million by the year 2030 trailing a CAGR of 12.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.8% and 7.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Medical Equipment Third Party Calibration Services Market - Key Trends & Drivers Summarized

Is Outsourcing Calibration the Hidden Backbone of Medical Device Reliability?

Calibration of medical equipment has evolved into a mission-critical element in modern healthcare, particularly as hospitals and diagnostic centers increasingly rely on high-precision technologies to ensure optimal patient care. Third party calibration services have emerged as a strategic enabler, offering specialized, certified expertise that supports the regulatory, operational, and clinical requirements of a wide range of medical devices. The transition from in-house maintenance models to outsourced calibration is being driven by the need for faster turnaround, heightened accuracy, and adherence to international standards such as ISO/IEC 17025. These standards not only ensure the credibility of calibration outcomes but also enhance the traceability and audit readiness of healthcare institutions. While internal biomedical engineering departments still handle routine servicing, they often lack the necessary certifications and environmental controls to perform high-precision calibration, particularly for sophisticated imaging, infusion, and diagnostic systems. This has paved the way for independent calibration firms equipped with environmentally controlled labs, automated calibration rigs, and cross-platform device testing capabilities. As the global healthcare landscape shifts towards preventive maintenance models, third party calibration plays a key role in reducing equipment downtime and extending device lifecycles. Increasing complexity of medical technologies, such as MRI scanners, patient monitoring systems, and infusion pumps, also necessitates specialist calibration interventions that cannot be efficiently managed in-house. The third party calibration industry is not merely filling a gap-it is optimizing the value chain for both public and private healthcare providers.

How Are Regulations and Compliance Pressure Shaping the Demand for Calibration Expertise?

The growing regulatory burden on healthcare providers worldwide has sharply amplified the importance of traceable, documented, and standards-compliant calibration services. Regulatory bodies across geographies-including the U.S. FDA, the European Medicines Agency, and various national healthcare commissions-now mandate periodic calibration of medical equipment as a part of their quality control frameworks. Failure to comply can result in penalties, suspension of services, or even patient litigation in cases of diagnostic errors or treatment failures caused by equipment inaccuracies. Third party calibration firms are increasingly viewed as compliance partners rather than vendors, providing end-to-end documentation, audit support, and calibration certificates that align with evolving standards and inspection requirements. Furthermore, rising patient safety concerns are translating into strict protocols for device reliability, especially in high-risk departments such as radiology, surgery, cardiology, and intensive care. Even minor deviations in equipment readings-such as infusion volumes, ECG signals, or ventilator pressures-can lead to severe clinical consequences, emphasizing the need for expert-led calibration. Beyond clinical relevance, calibration also supports hospital-wide quality assurance goals including Six Sigma initiatives and Joint Commission accreditation. As new technologies such as wireless infusion systems, portable diagnostics, and robotic-assisted surgical devices proliferate, regulators are also updating calibration protocols to keep pace. This is prompting healthcare institutions to turn to calibration specialists capable of offering traceability, data logging, performance analytics, and even remote diagnostics to preemptively detect faults. Compliance, once seen as a checkbox, is now a core operational imperative driving the expansion of the third party calibration ecosystem.

What Role Do End-Use Industries and Equipment Complexity Play in Driving the Service Landscape?

The scope of third party calibration services is rapidly expanding across diverse end-use verticals such as hospitals, ambulatory surgery centers, pathology labs, home healthcare providers, and diagnostic imaging clinics. Each segment has distinct calibration needs, determined by equipment usage patterns, risk profiles, and service frequency requirements. For example, high-usage environments like emergency rooms and ICUs require more frequent calibration of patient monitors, defibrillators, and anesthesia delivery systems to mitigate the risks of sensor drift or parameter misalignment. On the other hand, outpatient clinics often rely on calibration for ECG machines, spirometers, and digital thermometry tools used intermittently but still requiring precision. Additionally, with the increasing popularity of mobile healthcare and telemedicine, portable medical equipment-including handheld ultrasound probes and point-of-care diagnostic devices-has entered the calibration radar. The challenge lies in the miniaturization and digitization of medical equipment, which requires ultra-precise alignment, software synchronization, and validation across multiple sensors and modules. Third party providers are now investing in cloud-based calibration management software that automates inventory tracking, calibration scheduling, and historical analysis to meet the needs of sprawling healthcare networks. This has enhanced operational efficiencies for multi-location healthcare chains, which can outsource entire calibration workflows while retaining central oversight. Furthermore, medical OEMs are entering strategic alliances with independent calibration firms to bundle post-sale maintenance and compliance services as part of service-level agreements (SLAs), reducing the end-user burden. The rise in public-private partnerships in healthcare delivery across emerging markets has also triggered the demand for regionally accredited third party calibration centers, particularly for government-funded facilities.

The Growth in the Medical Equipment Third Party Calibration Services Market Is Driven by Several Factors…

Key growth drivers for this market lie in the intersection of healthcare digitization, device sophistication, and the increasing demand for regulatory transparency. At the technological front, the surge in advanced diagnostic and therapeutic systems-ranging from digital radiography and hemodialysis machines to robotic surgery platforms-is leading to a consistent demand for precise, frequent, and certified calibration services. These systems rely heavily on software-integrated hardware components, making them highly sensitive to minor fluctuations in sensor alignment, output calibration, or power metrics. As a result, original equipment manufacturers are increasingly advocating for third party calibrations to preserve equipment integrity and maintain warranty validity. From an end-user perspective, the trend towards cost containment and operational outsourcing is pushing hospitals and labs to delegate calibration to specialized vendors, thereby improving service quality while reducing internal workload. Additionally, as multi-vendor equipment portfolios become the norm in large hospitals, third party providers offer the unique advantage of cross-platform calibration, independent of OEM constraints. Consumer behavior is also evolving, with healthcare institutions now demanding real-time tracking of calibration history, predictive maintenance analytics, and integration of calibration data into centralized hospital asset management systems. Moreover, the regulatory environment is becoming increasingly favorable, with national health bodies endorsing third party calibration to ensure compliance and quality across both private and public sectors. In regions such as Europe and Asia-Pacific, the expansion of digital health programs and smart hospitals is driving up the installation base of precision medical devices, and consequently, the demand for certified calibration. The rise of mobile calibration services, where technicians visit healthcare facilities to conduct on-site calibration without disrupting daily operations, is further fueling service accessibility and adoption. In summary, this market is being shaped by a confluence of technological innovations, rising device interdependencies, diversified end-use demands, and intensifying compliance mandates-all of which are reinforcing the value proposition of third party calibration services in global healthcare.

SCOPE OF STUDY:

The report analyzes the Medical Equipment Third Party Calibration Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Hospitals, Clinical Laboratories, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â